Saturday, July 11, 2026

pharma · Allergies · Early Parkinson Disease

Advanced Accelerator Applications

Advanced Accelerator Applications is a pharma organization headquartered in RUEIL-MALMAISON, FR. Primary therapeutic focus areas include Allergies, Early Parkinson Disease, Breast Cancer, Recurrent or Metastatic Breast C

20 rue Diesel, Saint Genis Pouilly, 01630, FR, RUEIL-MALMAISON HQ
590 Employees
EMA registrant Type
Company details
Status
Public
HQ
20 rue Diesel, Saint Genis Pouilly, 01630, FR, RUEIL-MALMAISON
Employees
590
Programs
12
Drugs
25
Patents
25
Clinical program

K0706

Phase 2 · small molecule · Early Parkinson Disease

K0706 for Early Parkinson Disease is a Phase 2 program (small_molecule) at Advanced Accelerator Applications with 1 ClinicalTrials.gov record(s).

Internal code CLR_18_06

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Advanced Accelerator Applications
Phase
Phase 2
Modality
small_molecule
Indication
Early Parkinson Disease
Status
terminated
Trials
1